Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates

DOI record: { "DOI": "10.1038/s41586-020-2558-4", "ISSN": [ "0028-0836", "1476-4687" ], "URL": "http://dx.doi.org/10.1038/s41586-020-2558-4", "alternative-id": [ "2558" ], "assertion": [ { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Received", "name": "received", "order": 1, "value": "30 April 2020" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Accepted", "name": "accepted", "order": 2, "value": "10 July 2020" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "First Online", "name": "first_online", "order": 3, "value": "22 July 2020" }, { "group": { "label": "Competing interests", "name": "EthicsHeading" }, "name": "Ethics", "order": 1, "value": "J.G. has worked as consultant for Roche." }, { "label": "Free to read", "name": "free", "value": "This content has been made available to all." } ], "author": [ { "ORCID": "http://orcid.org/0000-0002-0555-207X", "affiliation": [], "authenticated-orcid": false, "family": "Maisonnasse", "given": "Pauline", "sequence": "first" }, { "ORCID": "http://orcid.org/0000-0002-5534-5482", "affiliation": [], "authenticated-orcid": false, "family": "Guedj", "given": "Jérémie", "sequence": "additional" }, { "affiliation": [], "family": "Contreras", "given": "Vanessa", "sequence": "additional" }, { "affiliation": [], "family": "Behillil", "given": "Sylvie", "sequence": "additional" }, { "affiliation": [], "family": "Solas", "given": "Caroline", "sequence": "additional" }, { "affiliation": [], "family": "Marlin", "given": "Romain", "sequence": "additional" }, { "affiliation": [], "family": "Naninck", "given": "Thibaut", "sequence": "additional" }, { "affiliation": [], "family": "Pizzorno", "given": "Andres", "sequence": "additional" }, { "affiliation": [], "family": "Lemaitre", "given": "Julien", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0002-8759-2429", "affiliation": [], "authenticated-orcid": false, "family": "Gonçalves", "given": "Antonio", "sequence": "additional" }, { "affiliation": [], "family": "Kahlaoui", "given": "Nidhal", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0001-9393-7684", "affiliation": [], "authenticated-orcid": false, "family": "Terrier", "given": "Olivier", "sequence": "additional" }, { "affiliation": [], "family": "Fang", "given": "Raphael Ho Tsong", "sequence": "additional" }, { "affiliation": [], "family": "Enouf", "given": "Vincent", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0001-6682-6313", "affiliation": [], "authenticated-orcid": false, "family": "Dereuddre-Bosquet", "given": "Nathalie", "sequence": "additional" }, { "affiliation": [], "family": "Brisebarre", "given": "Angela", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0002-4734-2249", "affiliation": [], "authenticated-orcid": false, "family": "Touret", "given": "Franck", "sequence": "additional" }, { "affiliation": [], "family": "Chapon", "given": "Catherine", "sequence": "additional" }, { "affiliation": [], "family": "Hoen", "given": "Bruno", "sequence": "additional" }, { "affiliation": [], "family": "Lina", "given": "Bruno", "sequence": "additional" }, { "affiliation": [], "family": "Calatrava", "given": "Manuel Rosa", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0002-1148-4456", "affiliation": [], "authenticated-orcid": false, "family": "van der Werf", "given": "Sylvie", "sequence": "additional" }, { "affiliation": [], "family": "de Lamballerie", "given": "Xavier", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0002-4928-4484", "affiliation": [], "authenticated-orcid": false, "family": "Le Grand", "given": "Roger", "sequence": "additional" } ], "container-title": "Nature", "container-title-short": "Nature", "content-domain": { "crossmark-restriction": false, "domain": [ "link.springer.com" ] }, "created": { "date-parts": [ [ 2020, 7, 22 ] ], "date-time": "2020-07-22T10:04:54Z", "timestamp": 1595412294000 }, "deposited": { "date-parts": [ [ 2023, 5, 20 ] ], "date-time": "2023-05-20T22:07:11Z", "timestamp": 1684620431000 }, "indexed": { "date-parts": [ [ 2024, 5, 14 ] ], "date-time": "2024-05-14T18:39:12Z", "timestamp": 1715711952966 }, "is-referenced-by-count": 267, "issue": "7826", "issued": { "date-parts": [ [ 2020, 7, 22 ] ] }, "journal-issue": { "issue": "7826", "published-print": { "date-parts": [ [ 2020, 9, 24 ] ] } }, "language": "en", "license": [ { "URL": "https://www.springer.com/tdm", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2020, 7, 22 ] ], "date-time": "2020-07-22T00:00:00Z", "timestamp": 1595376000000 } }, { "URL": "https://www.springer.com/tdm", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2020, 7, 22 ] ], "date-time": "2020-07-22T00:00:00Z", "timestamp": 1595376000000 } } ], "link": [ { "URL": "http://www.nature.com/articles/s41586-020-2558-4.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "http://www.nature.com/articles/s41586-020-2558-4", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "http://www.nature.com/articles/s41586-020-2558-4.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "297", "original-title": [], "page": "584-587", "prefix": "10.1038", "published": { "date-parts": [ [ 2020, 7, 22 ] ] }, "published-online": { "date-parts": [ [ 2020, 7, 22 ] ] }, "published-print": { "date-parts": [ [ 2020, 9, 24 ] ] }, "publisher": "Springer Science and Business Media LLC", "reference": [ { "DOI": "10.1038/s41591-020-0869-5", "author": "X He", "doi-asserted-by": "publisher", "first-page": "672", "journal-title": "Nat. Med.", "key": "2558_CR1", "unstructured": "He, X. et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat. Med. 26, 672–675 (2020).", "volume": "26", "year": "2020" }, { "DOI": "10.1016/S0140-6736(20)30183-5", "author": "C Huang", "doi-asserted-by": "publisher", "first-page": "497", "journal-title": "Lancet", "key": "2558_CR2", "unstructured": "Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497–506 (2020).", "volume": "395", "year": "2020" }, { "DOI": "10.1172/JCI137244", "author": "G Chen", "doi-asserted-by": "publisher", "first-page": "2620", "journal-title": "J. Clin. Invest.", "key": "2558_CR3", "unstructured": "Chen, G. et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Invest. 130, 2620–2629 (2020).", "volume": "130", "year": "2020" }, { "DOI": "10.1016/j.antiviral.2020.104762", "author": "F Touret", "doi-asserted-by": "publisher", "first-page": "104762", "journal-title": "Antiviral Res.", "key": "2558_CR4", "unstructured": "Touret, F. & de Lamballerie, X. Of chloroquine and COVID-19. Antiviral Res. 177, 104762 (2020).", "volume": "177", "year": "2020" }, { "DOI": "10.1038/s41598-020-70143-6", "author": "F Touret", "doi-asserted-by": "publisher", "journal-title": "Sci. Rep.", "key": "2558_CR5", "unstructured": "Touret, F. et al. In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication. Sci. Rep. 10, 13093 (2020).", "volume": "10", "year": "2020" }, { "DOI": "10.1016/j.tmaid.2020.101663", "author": "P Gautret", "doi-asserted-by": "publisher", "first-page": "101663", "journal-title": "Travel Med. Infect. Dis.", "key": "2558_CR6", "unstructured": "Gautret, P. et al. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: a pilot observational study. Travel Med. Infect. Dis. 34, 101663 (2020).", "volume": "34", "year": "2020" }, { "DOI": "10.1016/j.medj.2020.06.001", "author": "J Magagnoli", "doi-asserted-by": "crossref", "first-page": "1", "journal-title": "Med", "key": "2558_CR7", "unstructured": "Magagnoli, J. et al. Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19. Med 1, 1–14 (2020).", "volume": "1", "year": "2020" }, { "DOI": "10.1056/NEJMoa2001316", "author": "Q Li", "doi-asserted-by": "publisher", "first-page": "1199", "journal-title": "N. Engl. J. Med.", "key": "2558_CR8", "unstructured": "Li, Q. et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N. Engl. J. Med. 382, 1199–1207 (2020).", "volume": "382", "year": "2020" }, { "DOI": "10.1038/s41422-020-0282-0", "author": "M Wang", "doi-asserted-by": "publisher", "first-page": "269", "journal-title": "Cell Res.", "key": "2558_CR9", "unstructured": "Wang, M. et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 30, 269–271 (2020).", "volume": "30", "year": "2020" }, { "DOI": "10.1038/s41421-020-0156-0", "author": "J Liu", "doi-asserted-by": "publisher", "first-page": "16", "journal-title": "Cell Discov.", "key": "2558_CR10", "unstructured": "Liu, J. et al. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov. 6, 16 (2020).", "volume": "6", "year": "2020" }, { "DOI": "10.1080/14740338.2017.1269168", "author": "C Ponticelli", "doi-asserted-by": "publisher", "first-page": "411", "journal-title": "Expert Opin. Drug Saf.", "key": "2558_CR11", "unstructured": "Ponticelli, C. & Moroni, G. Hydroxychloroquine in systemic lupus erythematosus (SLE). Expert Opin. Drug Saf. 16, 411–419 (2017).", "volume": "16", "year": "2017" }, { "DOI": "10.1016/S1473-3099(06)70361-9", "author": "A Savarino", "doi-asserted-by": "publisher", "first-page": "67", "journal-title": "Lancet Infect. Dis.", "key": "2558_CR12", "unstructured": "Savarino, A., Di Trani, L., Donatelli, I., Cauda, R. & Cassone, A. New insights into the antiviral effects of chloroquine. Lancet Infect. Dis. 6, 67–69 (2006).", "volume": "6", "year": "2006" }, { "DOI": "10.1007/s10787-015-0239-y", "author": "KD Rainsford", "doi-asserted-by": "publisher", "first-page": "231", "journal-title": "Inflammopharmacology", "key": "2558_CR13", "unstructured": "Rainsford, K. D., Parke, A. L., Clifford-Rashotte, M. & Kean, W. F. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases. Inflammopharmacology 23, 231–269 (2015).", "volume": "23", "year": "2015" }, { "DOI": "10.1038/s41584-020-0372-x", "author": "E Schrezenmeier", "doi-asserted-by": "publisher", "first-page": "155", "journal-title": "Nat. Rev. Rheumatol.", "key": "2558_CR14", "unstructured": "Schrezenmeier, E. & Dörner, T. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat. Rev. Rheumatol. 16, 155–166 (2020).", "volume": "16", "year": "2020" }, { "DOI": "10.1007/s10787-018-0512-y", "author": "SM Monzavi", "doi-asserted-by": "publisher", "first-page": "1175", "journal-title": "Inflammopharmacology", "key": "2558_CR15", "unstructured": "Monzavi, S. M. et al. Efficacy analysis of hydroxychloroquine therapy in systemic lupus erythematosus: a study on disease activity and immunological biomarkers. Inflammopharmacology 26, 1175–1182 (2018).", "volume": "26", "year": "2018" }, { "DOI": "10.1136/annrheumdis-2020-216924", "author": "A Fanouriakis", "doi-asserted-by": "crossref", "first-page": "713", "journal-title": "Ann. Rheum. Dis.", "key": "2558_CR16", "unstructured": "Fanouriakis, A. et al. 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis. Ann. Rheum. Dis. 79, 713–723 (2020).", "volume": "79", "year": "2020" }, { "DOI": "10.1111/cns.13092", "author": "B Zhang", "doi-asserted-by": "publisher", "first-page": "591", "journal-title": "CNS Neurosci. Ther.", "key": "2558_CR17", "unstructured": "Zhang, B. et al. Macrolide derivatives reduce proinflammatory macrophage activation and macrophage-mediated neurotoxicity. CNS Neurosci. Ther. 25, 591–600 (2019).", "volume": "25", "year": "2019" }, { "DOI": "10.1126/science.abb7314", "author": "B Rockx", "doi-asserted-by": "publisher", "first-page": "1012", "journal-title": "Science", "key": "2558_CR18", "unstructured": "Rockx, B. et al. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. Science 368, 1012–1015 (2020).", "volume": "368", "year": "2020" }, { "DOI": "10.1038/s41586-020-2423-5", "doi-asserted-by": "publisher", "key": "2558_CR19", "unstructured": "Williamson, B. N. et al. Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2. Nature https://doi.org/10.1038/s41586-020-2423-5 (2020)." }, { "DOI": "10.1038/s41586-020-2381-y", "author": "R Shi", "doi-asserted-by": "publisher", "first-page": "120", "journal-title": "Nature", "key": "2558_CR20", "unstructured": "Shi, R. et al. A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2. Nature 584, 120–124 (2020).", "volume": "584", "year": "2020" }, { "DOI": "10.1093/cid/ciaa237", "author": "X Yao", "doi-asserted-by": "publisher", "first-page": "732", "journal-title": "Clin. Infect. Dis.", "key": "2558_CR21", "unstructured": "Yao, X. et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin. Infect. Dis. 71, 732–739 (2020).", "volume": "71", "year": "2020" }, { "DOI": "10.1038/s41598-019-48013-7", "author": "C Nicolas de Lamballerie", "doi-asserted-by": "publisher", "journal-title": "Sci. Rep.", "key": "2558_CR22", "unstructured": "Nicolas de Lamballerie, C. et al. Characterization of cellular transcriptomic signatures induced by different respiratory viruses in human reconstituted airway epithelia. Sci. Rep. 9, 11493 (2019).", "volume": "9", "year": "2019" }, { "DOI": "10.1016/j.xcrm.2020.100059", "author": "A Pizzorno", "doi-asserted-by": "publisher", "first-page": "100059", "journal-title": "Cell. Rep. Med", "key": "2558_CR23", "unstructured": "Pizzorno, A. et al. Characterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epithelia. Cell. Rep. Med 1, 100059 (2020).", "volume": "1", "year": "2020" }, { "DOI": "10.1148/radiol.2020200370", "author": "F Pan", "doi-asserted-by": "publisher", "first-page": "715", "journal-title": "Radiology", "key": "2558_CR24", "unstructured": "Pan, F. et al. Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19). Radiology 295, 715–721 (2020).", "volume": "295", "year": "2020" }, { "DOI": "10.1016/S1473-3099(20)30086-4", "author": "H Shi", "doi-asserted-by": "publisher", "first-page": "425", "journal-title": "Lancet Infect. Dis.", "key": "2558_CR25", "unstructured": "Shi, H. et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect. Dis. 20, 425–434 (2020).", "volume": "20", "year": "2020" }, { "DOI": "10.1111/j.1365-2125.1988.tb05281.x", "author": "SE Tett", "doi-asserted-by": "publisher", "first-page": "303", "journal-title": "Br. J. Clin. Pharmacol.", "key": "2558_CR26", "unstructured": "Tett, S. E., Cutler, D. J., Day, R. O. & Brown, K. F. A dose-ranging study of the pharmacokinetics of hydroxy-chloroquine following intravenous administration to healthy volunteers. Br. J. Clin. Pharmacol. 26, 303–313 (1988).", "volume": "26", "year": "1988" }, { "DOI": "10.1016/S1473-3099(20)30232-2", "author": "Y Liu", "doi-asserted-by": "publisher", "first-page": "656", "journal-title": "Lancet Infect. Dis.", "key": "2558_CR27", "unstructured": "Liu, Y. et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect. Dis. 20, 656–657 (2020).", "volume": "20", "year": "2020" }, { "DOI": "10.1016/S0140-6736(20)30211-7", "author": "N Chen", "doi-asserted-by": "publisher", "first-page": "507", "journal-title": "Lancet", "key": "2558_CR28", "unstructured": "Chen, N. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395, 507–513 (2020).", "volume": "395", "year": "2020" }, { "DOI": "10.3390/v10050268", "author": "P Roques", "doi-asserted-by": "publisher", "first-page": "268", "journal-title": "Viruses", "key": "2558_CR29", "unstructured": "Roques, P. et al. Paradoxical effect of chloroquine treatment in enhancing chikungunya virus infection. Viruses 10, 268 (2018).", "volume": "10", "year": "2018" }, { "DOI": "10.1016/j.jchromb.2017.11.026", "author": "YS Chhonker", "doi-asserted-by": "publisher", "first-page": "320", "journal-title": "J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.", "key": "2558_CR30", "unstructured": "Chhonker, Y. S., Sleightholm, R. L., Li, J., Oupický, D. & Murry, D. J. Simultaneous quantitation of hydroxychloroquine and its metabolites in mouse blood and tissues using LC-ESI-MS/MS: an application for pharmacokinetic studies. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 1072, 320–327 (2018).", "volume": "1072", "year": "2018" }, { "DOI": "10.1016/S1473-3099(20)30200-0", "author": "FX Lescure", "doi-asserted-by": "publisher", "first-page": "697", "journal-title": "Lancet Infect. Dis.", "key": "2558_CR31", "unstructured": "Lescure, F. X. et al. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect. Dis. 20, 697–706 (2020).", "volume": "20", "year": "2020" } ], "reference-count": 31, "references-count": 31, "relation": {}, "resource": { "primary": { "URL": "https://www.nature.com/articles/s41586-020-2558-4" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "volume": "585" }